non-invasive bladder urothelial carcinoma
non-invasive bladder urothelial carcinoma
Explore linked clinical trials. Standard reference: MONDO:00039304 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer | bladder carcinoma in situ, non-invasive bladder urothelial carcinoma | Active, not recruiting | Phase 3 | 2026-03-23 | NCT03091660 | |
| Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC) | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, non-invasive bladder urothelial carcinoma, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Phase 3 | 2026-03-20 | NCT05037279 | |
| Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, non-invasive bladder urothelial carcinoma, transitional cell carcinoma, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, urothelial carcinoma | Active, not recruiting | Phase 1 | 2025-12-04 | NCT05768347 | |
| Intravesical BCG: is the Urinary Bladder Ready to Receive it | non-invasive bladder urothelial carcinoma | Not yet recruiting | Not stated | 2022-06-09 | NCT05335512 |